The DOI matches its Crossref record.
The Role of Corticotropin-Releasing Factor in the Pathogenesis of Major Depression
Abstract
It is well established that corticotropin-releasing factor (CRF), a peptide comprised of 41 amino acids, is the major physiological regulator of the pituitary-adrenal axis by virtue of its role as the hypothalamic hypophysiotropic hormone that modulates the secretion of adrenocorticotropin (ACTH) from the anterior pituitary gland. In addition to its neuroendocrine role, CRF appears to function as a neurotransmitter or neuromodulator in extrahypothalamic brain areas. The peptide and its receptors are distributed throughout the central nervous system (CNS), and CRF is released by depolarizing concentrations of potassium in a calcium-dependent manner. After direct CNS administration, CRF produces a number of behavioral and physiological effects that are reminiscent of both an organism's response to stress and to the symptoms of patients with major depression. These include: diminished food consumption, decreased sexual behavior, disturbed sleep, alterations in locomotor activity and sympathetic nervous system activation. Alterations in regional brain CRF concentration in rats were observed after acute and chronic stress, i.e. decreased hypothalamic and increased locus coeruleus CRF concentrations. To test the hypothesis that CRF is hypersecreted in patients with major depression, the concentration of CRF in cerebrospinal fluid (CSF) in drug-free depressed patients and age- and sex-matched controles was measured in two studies. The depressed patients exhibited a clear grouprelated increase in CSF CRF concentrations. To further test this hypothesis that CRF is chronically hypersecreted in depressed patients, the number and affinity of CRF receptors in frontal cortex was measured in a group of suicides and age-matched controls. A significant reduction in the number (Bmax) of CRF receptors, without any change in affinity (K D ), was found in the suicide victims, consistent with CRF receptor down-regulation in response to chronic CRF hypersecretion. These findings, taken together, support the hypothesis that CRF is hypersecreted in the CNS of patients with major depression. Zusammenfassung Einer gut gesicherten Erkenntnis zufolge ist der Corticotropin Releasing Factor (CRF), der ein aus 41 Aminosäuren bestehendes Peptid ist, der maßgebliche physiologische Regler der Hirnanhangs-Nebennierenachse aufgrund seiner Rolle als hypothalamisches hypophysiotropes Hormon, welches die ACTH-Sekretion des Hypophysenvorderlappens moduliert. Zusätzlich zu seiner neuroendokrinen Funktion scheint CRF auch eine Rolle als Transmitter oder Neuromodulator im außerhypothalamischen Hirnbereich zu spielen. Die Peptide und ihre Rezeptoren sind im gesamten Zentralnervensystem (ZNS) verteilt und der CRF wird durch kalziumabhängige Entpolarisierung von Kaliumkonzentrationen freigesetzt. Nach direkter Einschleusung in das ZNS ruft CRF eine Reihe von Verhaltens- und physiologischen Wirkungen hervor, die sowohl an die Reaktion eines Organismus auf Streß als auch an die Symptome von Patienten mit dem Vollbild einer Depression erinnern, darunter u.a. verminderte Nahrungseinnahme, herabgesetzte Sexualaktivität, Schlafstörungen, Veränderungen der motorischen Aktivität und Aktivierung des Sympathikussystems. In Ratten wurden nach akutem und chronischem Streß Veränderungen der CRF-Konzentration im Gehirn beobachtet, d.h. eine Konzentrationsabnahme im Hypothalamusbereich und eine Zunahme im Locus coeruleus. Zur Prüfung der Hypothese, daß CRF bei Patienten mit voll ausgeprägter Depression im Übermaß freigesetzt wird, wurde die CRF-Konzentration im Liquor von depressiven Patienten, denen kein Medikament verabreicht worden war, sowie von Probanden entsprechenden Alters und Geschlechts in zwei Studien gemessen. Bei den depressiven Patienten zeigte sich eine eindeutige gruppenbezogene Zunahme der CRF-Konzentrationen im Liquor. Um die Hypothese zu überprüfen, daß CRF bei depressiven Patienten chronisch übermäßig freigesetzt wird, wurden in einer Gruppe von Selbstmördern und altersmäßig gleichartigen Probanden die Anzahl und die Affinität von CRF-Rezeptoren im frontalen Bereich der Großhirnrinde gemessen. Wir stellten eine signifikante Verringerung der Anzahl (Bmax) der CRF-Rezeptoren ohne Veränderung der Affinität (K D ) bei den Selbstmördern fest, im Einklang mit der Dämpfung der CRF-Rezeptoren als Reaktion auf chronische Hypersekretion von CRF. Alle diese Befunde zusammengenommen unterstützen die Hypothese, daß bei Patienten mit voll ausgeprägter Depression eine CRF-Hypersekretion in das Zentralnervensystem stattfindet.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Dunn, A. J., & Berridge, C. W. (1990) · Brain Research Reviews · doi:10.1016/0165-0173(90)90012-d · Cited by 1,352
CRF and CRF receptors: role in stress responsivity and other behaviors
Bale, T. L., & Vale, W. W. (2004) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.44.101802.121410 · Cited by 1,270
Binder, E. B., Salyakina, D., Lichtner, P., Wochnik, G. M., Ising, M., Pütz, B., Papiol, S., Seaman, S., Lucae, S., Kohli, M. A., et al. (2004) · Nature Genetics · doi:10.1038/ng1479 · Cited by 977
Neuroendocrine pharmacology of stress
Carrasco, G. A., & Van de Kar, L. D. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01285-8 · Cited by 914
“Whereas some authors found a decreased expression in postmortem brains of suicide victims (Nemeroff, 1988) others did not find any difference (Hucks et al.”
BackgroundPrenatal stress and long-term consequences: implications of glucocorticoid hormones
Maccari, S., Darnaudery, M., Morley-Fletcher, S., Zuena, A. R., Cinque, C., & Van Reeth, O. (2003) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(03)00014-9 · Cited by 529
Stenzel-Poore, M., Heinrichs, S., Rivest, S., Koob, G., & Vale, W. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-05-02579.1994 · Cited by 468
Neuroendocrine aspects of hypercortisolism in major depression
Parker, K. J., Schatzberg, A. F., & Lyons, D. M. (2003) · Hormones and Behavior · doi:10.1016/s0018-506x(02)00016-8 · Cited by 455
Decreased Food Intake With Aging
Morley, J. E. (2001) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/56.suppl_2.81 · Cited by 424
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.9.1372 · Cited by 411
Schulz, D. W., Mansbach, R. S., Sprouse, J., Braselton, J. P., Collins, J., Corman, M., Dunaiskis, A., Faraci, S., Schmidt, A. W., Seeger, T., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.19.10477 · Cited by 377
Jesulola, E., Micalos, P., & Baguley, I. J. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.12.025 · Cited by 379
The Flinders sensitive line rats: a genetic animal model of depression
Overstreet, D. H. (1993) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(05)80230-1 · Cited by 369
Hauger, R., Risbrough, V., Brauns, O., & Dautzenberg, F. (2006) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152706777950684 · Cited by 343
The DST as a predictor of outcome in depression: a meta-analysis
Ribeiro, S. C. M., Tandon, R., Grunhaus, L., & Greden, J. F. (1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.11.1618 · Cited by 329
Koehl, M., Darnaud�ry, M., Dulluc, J., Van Reeth, O., Moal, M. L., & Maccari, S. (1999) · Journal of Neurobiology · doi:10.1002/(sici)1097-4695(19990905)40:3<302::aid-neu3>3.0.co;2-7 · Cited by 303
Goeders, N. E., & Guerin, G. F. (1994) · Psychopharmacology · doi:10.1007/bf02245445 · Cited by 288
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.1.93 · Cited by 275
Nemeroff, C. B., Bissette, G., Akil, H., & Fink, M. (1991) · British Journal of Psychiatry · doi:10.1192/bjp.158.1.59 · Cited by 254
Self-citationNeuropeptide receptor ligands as drugs for psychiatric diseases: the end of the beginning?
Griebel, G., & Holsboer, F. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3702 · Cited by 194
Huang, G.-J., & Herbert, J. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.09.016 · Cited by 165
Stress and Disease: Is Being Female a Predisposing Factor?
Becker, J. B., Monteggia, L. M., Perrot-Sinal, T. S., Romeo, R. D., Taylor, J. R., Yehuda, R., & Bale, T. L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3565-07.2007 · Cited by 158
Banki, C. M., Karmacsi, L., Bissette, G., & Nemeroff, C. B. (1992) · European Neuropsychopharmacology · doi:10.1016/0924-977x(92)90019-5 · Cited by 149
Self-citationHsu, D. T., & Price, J. L. (2009) · Journal of Comparative Neurology · doi:10.1002/cne.21934 · Cited by 127
Gutman, D. A., & Nemeroff, C. B. (2003) · Physiology & Behavior · doi:10.1016/s0031-9384(03)00166-5 · Cited by 115
Self-citationBrunson, K. L., Avishai-Eliner, S., Hatalski, C. G., & Baram, T. Z. (2001) · Molecular Psychiatry · doi:10.1038/sj.mp.4000942 · Cited by 112
Young, A. H. (2004) · Stress · doi:10.1080/10253890500069189 · Cited by 111
“Over-secretion of CRH, resulting in hypercortisolaemia, may be normalised by blockade of CRH receptors (Nemeroff 1988).”
BackgroundRegev, L., Neufeld-Cohen, A., Tsoory, M., Kuperman, Y., Getselter, D., Gil, S., & Chen, A. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.64 · Cited by 110
Regev, L., Tsoory, M., Gil, S., & Chen, A. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.05.036 · Cited by 93
Sex differences in hormonal responses to a social stressor in chronic major depression
Chopra, K. K., Ravindran, A., Kennedy, S. H., Mackenzie, B., Matthews, S., Anisman, H., Bagby, R. M., Farvolden, P., & Levitan, R. D. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.03.014 · Cited by 86
Pituitary volume and third ventricle width in euthymic patients with bipolar disorder
Cousins, D. A., Brian Moore, P., Watson, S., Harrison, L., Nicol Ferrier, I., Young, A. H., & Lloyd, A. J. (2010) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2010.01.008 · Cited by 24
Metadata
- Authors
- Nemeroff, C.
- Venue
- Pharmacopsychiatry
- Publisher
- Georg Thieme Verlag KG
- Published
- 1988-03
- Volume
- 21
- Issue
- 02
- Pages
- 76-82
- ISSN
- 0176-3679 (ISSN-L)
- 1439-0795
- OpenAlex
- W2088953612
- Cited by
- 185
- References
- 0
- FWCI
- 3.78
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.